These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22298594)

  • 1. Cancer stem cells: distinct entities or dynamically regulated phenotypes?
    Li Y; Laterra J
    Cancer Res; 2012 Feb; 72(3):576-80. PubMed ID: 22298594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.
    Lopez-Bertoni H; Li Y; Laterra J
    Biol Med (Aligarh); 2015 Nov; 7(Suppl 2):. PubMed ID: 27158195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic regulation of cancer stem cells and clinical challenges.
    Ni C; Huang J
    Clin Transl Oncol; 2013 Apr; 15(4):253-8. PubMed ID: 22926945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.
    Yasuda H; Soejima K; Watanabe H; Kawada I; Nakachi I; Yoda S; Nakayama S; Satomi R; Ikemura S; Terai H; Sato T; Suzuki S; Matsuzaki Y; Naoki K; Ishizaka A
    Int J Oncol; 2010 Dec; 37(6):1537-46. PubMed ID: 21042723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
    Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
    Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dualistic origin of human tumors.
    Liu J
    Semin Cancer Biol; 2018 Dec; 53():1-16. PubMed ID: 30040989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of Krüppel-like factor 4 in cancer and cancer stem cells.
    Ding B; Liu P; Liu W; Sun P; Wang CL
    Asian Pac J Cancer Prev; 2015; 16(9):3629-33. PubMed ID: 25987013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
    Hen O; Barkan D
    Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem-cell signaling network and resistance to therapy.
    Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
    Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.
    Lin Q; Yun Z
    Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-tumor heterogeneity from a cancer stem cell perspective.
    Prasetyanti PR; Medema JP
    Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer stem cells as a possible source of tumor initiation and progression].
    Puchinskaya MV
    Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of microRNAs in cancer and cancer stem cells.
    Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
    J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
    Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
    Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.